Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for ImmunoTech (AIM) over the last 9 years, with Q3 2025 value amounting to $4.3 million.

  • ImmunoTech's Total Non-Current Liabilities changed N/A to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year change of. This contributed to the annual value of $7.3 million for FY2019, which is 466.49% down from last year.
  • Per ImmunoTech's latest filing, its Total Non-Current Liabilities stood at $4.3 million for Q3 2025.
  • In the past 5 years, ImmunoTech's Total Non-Current Liabilities registered a high of $4.3 million during Q3 2025, and its lowest value of $4.3 million during Q3 2025.